Literature DB >> 15700030

Pharmacological neutropenia prevents endothelial dysfunction but not smooth muscle functions impairment induced by middle cerebral artery occlusion.

Olivier Pétrault1, Thavarak Ouk, Sophie Gautier, Maud Laprais, Patrick Gelé, Michèle Bastide, Régis Bordet.   

Abstract

1. The polymorphonuclear neutrophils (PMN) activation and mobilization observed in acute cerebral infarction contribute to the brain tissue damage, but PMN could also be involved in postischemic functional injury of ischemied blood vessel. 2. This study was undertaken to investigate whether pharmacological neutropenia could modify the postischemic endothelial dysfunction in comparison to smooth muscle whose impairment is likely more related to reperfusion and oxidative stress. 3. A cerebral ischemia-reperfusion by endoluminal occlusion of right middle cerebral artery (MCA) was performed 4 days after intravenous administration of vinblastine or 12 h after RP-3 anti-rat neutrophils monoclonal antibody (mAb RP-3) injection into the peritoneal cavity, on male Wistar rats with 1-h ischemia then followed by 24-h reperfusion period. Brain infarct volume was measured by histomorphometric analysis and vascular endothelial and smooth muscle reactivity of MCA was analysed using Halpern myograph. 4. Neutropenia induced a neuroprotective effect as demonstrated by a significant decrease of brain infarct size. In parallel to neuroprotection, neutropenia prevented postischemic impairment of endothelium-dependent relaxing response to acetylcholine. In contrast, smooth muscle functional alterations were not prevented by neutropenia. Ischemia-reperfusion-induced myogenic tone impairment remained unchanged in vinblastine and mAb RP-3-treated rats. Postischemic Kir2.x-dependent relaxation impairment was not prevented in neutropenic conditions. The fully relaxation of smooth muscle response to sodium nitroprusside was similar in all groups. 5. Our results evidenced the dissociate prevention of pharmacologically induced neutropenia on postischemic vascular endothelial and smooth muscle impairment. The selective endothelial protection by neutropenia is parallel to a neuroprotective effect suggesting a possible relationship between the two phenomena.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15700030      PMCID: PMC1576087          DOI: 10.1038/sj.bjp.0706124

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  42 in total

Review 1.  Nitric oxide and coronary endothelial dysfunction in humans.

Authors:  H Drexler
Journal:  Cardiovasc Res       Date:  1999-08-15       Impact factor: 10.787

Review 2.  Neutrophils: molecules, functions and pathophysiological aspects.

Authors:  V Witko-Sarsat; P Rieu; B Descamps-Latscha; P Lesavre; L Halbwachs-Mecarelli
Journal:  Lab Invest       Date:  2000-05       Impact factor: 5.662

Review 3.  Phagocytes and oxidative stress.

Authors:  B M Babior
Journal:  Am J Med       Date:  2000-07       Impact factor: 4.965

4.  Relationship between inward rectifier potassium current impairment and brain injury after cerebral ischemia/reperfusion.

Authors:  M Bastide; R Bordet; Q Pu; E Robin; F Puisieux; B Dupuis
Journal:  J Cereb Blood Flow Metab       Date:  1999-12       Impact factor: 6.200

5.  Intracisternal increase of superoxide anion production in a canine subarachnoid hemorrhage model.

Authors:  T Mori; K Nagata; T Town; J Tan; T Matsui; T Asano
Journal:  Stroke       Date:  2001-03       Impact factor: 7.914

6.  Expression of endothelial nitric oxide synthase in the ischemic penumbra: relationship to expression of neuronal nitric oxide synthase and vascular endothelial growth factor.

Authors:  R R Leker; A Teichner; H Ovadia; E Keshet; E Reinherz; T Ben-Hur
Journal:  Brain Res       Date:  2001-08-03       Impact factor: 3.252

7.  Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia.

Authors:  M Asahi; X Wang; T Mori; T Sumii; J C Jung; M A Moskowitz; M E Fini; E H Lo
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

Review 8.  Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress.

Authors:  H Cai; D G Harrison
Journal:  Circ Res       Date:  2000-11-10       Impact factor: 17.367

9.  Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94.

Authors:  M Asahi; K Asahi; J C Jung; G J del Zoppo; M E Fini; E H Lo
Journal:  J Cereb Blood Flow Metab       Date:  2000-12       Impact factor: 6.200

10.  Matrix metalloproteinase 2 gene knockout has no effect on acute brain injury after focal ischemia.

Authors:  M Asahi; T Sumii; M E Fini; S Itohara; E H Lo
Journal:  Neuroreport       Date:  2001-09-17       Impact factor: 1.837

View more
  13 in total

Review 1.  Mechanisms of I/R-Induced Endothelium-Dependent Vasodilator Dysfunction.

Authors:  Ronald J Korthuis
Journal:  Adv Pharmacol       Date:  2017-12-08

Review 2.  Cerebral Vascular Disease and Neurovascular Injury in Ischemic Stroke.

Authors:  Xiaoming Hu; T Michael De Silva; Jun Chen; Frank M Faraci
Journal:  Circ Res       Date:  2017-02-03       Impact factor: 17.367

3.  Neutrophil-To-Lymphocyte Ratio Predicts 3-Month Outcome of Acute Ischemic Stroke.

Authors:  Sen Qun; Yan Tang; Jing Sun; Zhaoxia Liu; Juncang Wu; Ji Zhang; Jidong Guo; Zhiqiang Xu; Dan Zhang; Zhengxu Chen; Fuyong Hu; Xingshun Xu; Wei Ge
Journal:  Neurotox Res       Date:  2017-02-08       Impact factor: 3.911

4.  Effects of the PPAR-α agonist fenofibrate on acute and short-term consequences of brain ischemia.

Authors:  Thavarak Ouk; Sophie Gautier; Maud Pétrault; David Montaigne; Xavier Maréchal; Isabelle Masse; Jean-Christophe Devedjian; Dominique Deplanque; Michèle Bastide; Rémi Nevière; Patrick Duriez; Bart Staels; Florence Pasquier; Didier Leys; Régis Bordet
Journal:  J Cereb Blood Flow Metab       Date:  2014-01-08       Impact factor: 6.200

Review 5.  Targeting neutrophils in ischemic stroke: translational insights from experimental studies.

Authors:  Glen C Jickling; DaZhi Liu; Bradley P Ander; Boryana Stamova; Xinhua Zhan; Frank R Sharp
Journal:  J Cereb Blood Flow Metab       Date:  2015-03-25       Impact factor: 6.200

Review 6.  Hemorrhagic transformation after ischemic stroke in animals and humans.

Authors:  Glen C Jickling; DaZhi Liu; Boryana Stamova; Bradley P Ander; Xinhua Zhan; Aigang Lu; Frank R Sharp
Journal:  J Cereb Blood Flow Metab       Date:  2013-11-27       Impact factor: 6.200

7.  Early treatment with atorvastatin exerts parenchymal and vascular protective effects in experimental cerebral ischaemia.

Authors:  C Potey; T Ouk; O Petrault; M Petrault; V Berezowski; J Salleron; R Bordet; S Gautier
Journal:  Br J Pharmacol       Date:  2015-10-06       Impact factor: 8.739

Review 8.  Peripheral polymorphonuclear leukocyte activation as a systemic inflammatory response in ischemic stroke.

Authors:  Xiaoye Mo; Ting Li; Guang Ji; Wei Lu; Zhiping Hu
Journal:  Neurol Sci       Date:  2013-04-26       Impact factor: 3.307

9.  Neutrophils contribute to intracerebral haemorrhages after treatment with recombinant tissue plasminogen activator following cerebral ischaemia.

Authors:  Sophie Gautier; Thavarak Ouk; Olivier Petrault; Jacques Caron; Régis Bordet
Journal:  Br J Pharmacol       Date:  2009-02-04       Impact factor: 8.739

10.  Higher neutrophil counts before thrombolysis for cerebral ischemia predict worse outcomes.

Authors:  Ilaria Maestrini; Daniel Strbian; Sophie Gautier; Elena Haapaniemi; Solène Moulin; Tiina Sairanen; Nelly Dequatre-Ponchelle; Gerli Sibolt; Charlotte Cordonnier; Susanna Melkas; Didier Leys; Turgut Tatlisumak; Régis Bordet
Journal:  Neurology       Date:  2015-09-11       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.